Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study von Guigay, J., Fayette, J., Dillies, A.F., Sire, C., Kerger, J.N., Tennevet, I., Machiels, J.P., Zanetta, S., Pointreau, Y., Bozec Le Moal, L., Henry, S., Schilf, A., Bourhis, J.

Volltext

Cancer and renal insufficiency results of the BIRMA study von Janus, N, Launay-vacher, V, Byloos, E, Machiels, J-P, Duck, L, Kerger, J, Wynendaele, W, Canon, J-L, Lybaert, W, Nortier, J, Deray, G, Wildiers, H

Volltext

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer von Vergote, I., Van Nieuwenhuysen, E., Casado, A., Laenen, A., Lorusso, D., Braicu, E.I., Guerra-Alia, E., Zola, P., Wimberger, P., Debruyne, P.R., Falcó, E., Ferrero, A., Muallem, M.Z., Kerger, J., García-Martinez, E., Pignata, S., Sehouli, J., Van Gorp, T., Gennigens, C., Rubio, M.J.

Volltext

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomark... von Seront, E., Rottey, S., Sautois, B., Kerger, J., D'Hondt, L.A., Verschaeve, V., Canon, J.-L., Dopchie, C., Vandenbulcke, J.M., Whenham, N., Goeminne, J.C., Clausse, M., Verhoeven, D., Glorieux, P., Branders, S., Dupont, P., Schoonjans, J., Feron, O., Machiels, J.-P.

Volltext

Potential Interactions with Anticancer Agents: A Cross-Sectional Study von Mouzon, A., Kerger, J., D'Hondt, L., Spinewine, A.

Volltext

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer von Machiels, J-P, Sempoux, C, Scalliet, P, Coche, J-C, Humblet, Y, Van Cutsem, E, Kerger, J, Canon, J-L, Peeters, M, Aydin, S, Laurent, S, Kartheuser, A, Coster, B, Roels, S, Daisne, J-F, Honhon, B, Duck, L, Kirkove, C, Bonny, M-A, Haustermans, K

Volltext

Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion von Vergote, I, Denys, H, Altintas, S, Kerger, J, Baurain, J-F, Bours, V, Henry, S, Van de Vijver, K, Lambrechts, D, Gennigens, C

Volltext

Treatment algorithm in patients with ovarian cancer von Vergote, I, Denys, H, De Greve, J, Gennigens, C, Van De Vijver, K, Kerger, J, Vuylsteke, P, Baurain, J F

Volltext

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer von Liberale, G., Pop, C.-F., Polastro, L., Kerger, J., Moreau, M., Chintinne, M., Larsimont, D., Nogaret, J.M., Veys, I.

Volltext

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study von Machiels, J.-P., Duck, L., Honhon, B., Coster, B., Coche, J.-C., Scalliet, P., Humblet, Y., Aydin, S., Kerger, J., Remouchamps, V., Canon, J.-L., Van Maele, P., Gilbeau, L., Laurent, S., Kirkove, C., Octave-Prignot, M., Baurain, J.-F., Kartheuser, A., Sempoux, C.

Volltext

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study von Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L

Volltext

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer von PICCART, Martine J, DI LEO, Angelo, CLOSON-DEJARDIN, Marie T, DUFRANE, Jean P, KERGER, Joseph, LIEBENS, Francoise, BEAUVOIS, Sylvie, BARTHOLOMEUS, Sylvie, DOLCI, Stella, LOBELLE, Jean P, PAESMANS, Marianne, NOGARET, Jean M, BEAUDUIN, Marc, VINDEVOGHEL, Anita, MICHEL, Jacques, FOCAN, Christian, TAGNON, Alain, RIES, Fernand, GOBERT, Philippe, FINET, Claude

Volltext

Molecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug Users von Aitken, Campbell K., McCaw, Rhonda F., Bowden, D. Scott, Tracy, Samantha L., Kelsall, Jenny G., Higgs, Peter G., Kerger, Michael J., Nguyen, Hoang, Crofts, J. Nick

Volltext

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study von Schrijvers, D., Van Herpen, C., Kerger, J., Joosens, E., Van Laer, C., Awada, A., Van den Weyngaert, D., Nguyen, H., Le Bouder, C., Castelijns, J. A., Kaanders, J., De Mulder, P., Vermorken, J. B.

Volltext

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients von de Wit, R, Kruit, WHJ, Stoter, G, de Boer, M, Kerger, J, Verweij, J

Volltext

Une approche radicale visant à obtenir une cytoréduction chirurgicale complète améliore la survie des patientes atteintes d’un cancer avancé de l’ovaire von Liberale, G., Pop, C.-F., Polastro, L., Kerger, J., Moreau, M., Chintinne, M., Larsimont, D., Nogaret, J.-M., Veys, I.

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

A single arm, open label, phase II, multicenter study to assess the detection of the BRAF V600 mutation on cfDNA from plasma in patients with advanced melanoma von Rutkowski, P., Pauwels, P., Kerger, J., Jacobs, B., Maertens, G.G., Gadeyne, V., Liebert, S., Neyns, B.

Volltext

1334P - A single arm, open label, phase II, multicenter study to assess the detection of the BRAF V600 mutation on cfDNA from plasma in patients with advanced melanoma von Rutkowski, P., Pauwels, P., Kerger, J., Jacobs, B., Maertens, G.G., Gadeyne, V., Liebert, S., Neyns, B.

Volltext

1334PA single arm, open label, phase II, multicenter study to assess the detection of the BRAF V600 mutation on cfDNA from plasma in patients with advanced melanoma von Rutkowski, P, Pauwels, P, Kerger, J, Jacobs, B, Maertens, G G, Gadeyne, V, Liebert, S, Neyns, B

Volltext